PT-141
Melanocortin receptor agonist for enhanced libido and sexual function.
What Is PT-141?
PT-141 (Bremelanotide) is a synthetic peptide derived from Melanotan II that acts on melanocortin-4 receptors (MC4R) in the central nervous system. Unlike every other sexual dysfunction treatment on the market – PDE5 inhibitors (Viagra, Cialis) that work on blood vessel mechanics – PT-141 enhances sexual desire at the neurological level, addressing the psychological and neurochemical roots of low libido rather than just the physical symptoms.
This distinction is critical: PDE5 inhibitors can produce an erection but cannot create desire. PT-141 works upstream, activating the brain pathways responsible for sexual arousal, motivation, and desire. This makes it effective for both men and women – a rarity in sexual health pharmaceuticals. In fact, PT-141 (under the brand name Vyleesi) received FDA approval in 2019 specifically for hypoactive sexual desire disorder (HSDD) in premenopausal women.
How PT-141 Enhances Sexual Function
- Central nervous system activation: PT-141 crosses the blood-brain barrier and binds to MC4R receptors in the hypothalamus – the brain region that governs sexual arousal, desire, and motivation. This triggers a neurochemical cascade that increases sexual interest and responsiveness.
- Dopamine pathway involvement: PT-141’s mechanism involves the dopaminergic reward pathways associated with desire and motivation, producing a natural-feeling increase in sexual interest rather than an artificial or forced arousal.
- Works for both sexes: Because it targets the brain’s desire centres rather than genital blood flow, PT-141 is effective for both men and women – one of the few compounds in sexual health that can make this claim.
- Complementary to PDE5 inhibitors: For men, PT-141 can be used alongside Viagra or Cialis. PT-141 addresses desire and arousal at the brain level, while PDE5 inhibitors address the physical mechanics. The combination addresses sexual function comprehensively.
- Extended duration: Effects typically begin 30–60 minutes after injection and can last 6–12 hours (sometimes up to 24 hours), providing a wide window of responsiveness rather than a timed “on/off” effect.
Clinical Evidence
PT-141 was evaluated in multiple clinical trials for both men and women. In men with erectile dysfunction, PT-141 produced erections in patients who had not responded to Viagra. In women with HSDD, clinical trials demonstrated statistically significant increases in sexual desire, arousal, and satisfying sexual events compared to placebo – leading to FDA approval as Vyleesi.
Who Uses PT-141?
PT-141 is used by men experiencing desire-related erectile dysfunction (where the physical mechanism works but desire/arousal is lacking), women with hypoactive sexual desire, couples looking to enhance intimacy, individuals on medications (SSRIs, antidepressants) that suppress libido as a side effect, and anyone experiencing age-related decline in sexual interest.
Obstet Gynecol, 2019. PubMed →
Ann N Y Acad Sci, 2003. PubMed →
Ther Adv Reprod Health, 2019. PubMed →
How to Use Your Peptides
A complete visual guide to preparing, reconstituting, injecting, and storing your peptides safely. Follow each step in order.
Preparation
Gather your supplies: peptide vial, bacteriostatic water, syringes, alcohol swabs, cotton ball, and bandage.
Remove the plastic caps from both vials to expose the rubber stoppers.
Wipe the top of each vial with an alcohol swab. Let air-dry.
Reconstitution
Draw the required amount of bacteriostatic water into the syringe. Use our calculator if unsure.
Inject the water slowly into the peptide vial, letting it run down the inside wall. Do not spray directly onto the powder.
Gently swirl the vial until the powder dissolves. Do not shake.
Check the solution: no undissolved particles, no bubbles, clear liquid. If not, wait and swirl again.
Draw your dose slowly from the reconstituted peptide vial.
Injection
Hold the syringe needle-up, flick to move air bubbles to the top, and push the plunger until a small drop appears.
Choose your injection site: belly fat around the navel or outer thigh. Rotate sites between injections.
Clean the injection site with an alcohol swab.
Pinch a fold of skin at the injection site to lift the subcutaneous fatty tissue away from the muscle.
Insert the needle at a 45° angle into the subcutaneous fatty tissue, usually approximately half the needle length. Do not inject into muscle. Inject slowly.
Aftercare, Storage & Disposal
Withdraw the needle and press a cotton ball gently on the site for a few seconds.
Apply a small bandage.
Dispose of the needle in a sharps container.
Store reconstituted peptides in the fridge (2-8 °C). Avoid freezing and direct sunlight. Use within 90 days.
Category-Specific Dosing Guides
Unlike many other sexual health peptides, PT-141 is typically used on an as-needed basis rather than as part of a daily protocol. Published studies and clinical use have generally evaluated intermittent administration with adequate spacing between doses.
Reconstitute
Add 2 ml of BAC water to the 10 mg vial to achieve a concentration of 5 mg/ml. At this concentration, 4 units on a U-100 insulin syringe corresponds to approximately 200 mcg, while 20 units corresponds to 1 mg. One vial typically provides 5-10 administrations, depending on the amount used per protocol.
Dosing
Clinical studies and commonly reported protocols have evaluated doses ranging from 1-2 mg administered subcutaneously approximately 45-60 minutes before anticipated activity. Many protocols begin at 1 mg before considering higher amounts. Published guidance generally recommends not exceeding 2 mg within a 24-hour period.
Frequency
This protocol is typically investigated as an intermittent protocol rather than a daily one. Common usage schedules involve no more than 2–3 administrations per week, with at least 24 hours between doses. Published reports describe activity lasting approximately 6–12 hours, with some observations extending beyond this range.
Side Effect Note
Nausea is among the most frequently reported adverse effects of Bremelanotide and was reported in approximately 40% of participants in clinical studies. Facial flushing has also been reported. As with any peptide protocol, the incidence and severity of side effects may vary between individuals and dosing regimens.
Works differently from PDE5 inhibitors - actual desire enhancement, not just mechanics. Noticeable effects within 2 hours of dosing.
One of the few options that works for women. The neurological approach is different and it shows. Very satisfied with results.
Effective product. Mild flushing on first use but diminished on subsequent doses. Dosing guide on the site was helpful.
The melanocortin pathway approach is fascinating and effective. Results felt natural, not forced. Much better than alternatives.
Works where PDE5 inhibitors alone were not enough. The desire component was the missing piece. Morpho quality is excellent.
Onset takes about 2-3 hours. Plan ahead. Effects are genuine and last well into the next day. Impressed with the product.
Discreet packaging and fast shipping. The product works as described in the research. Very professional supplier.
As a woman, options for desire enhancement are limited. PT-141 from Morpho has been genuinely helpful. Well-researched peptide.
Mild nausea on first use - starting with a lower dose helped. The neurological mechanism is noticeably different from Viagra.
Second order. Consistent quality and effects. The how-to-use guide on the product page was very helpful for first-time use.
Leave a Review
Share your experience. Your email won't be published.
Pre-filled for this product. Adjust values to match your protocol.
Why MorphoPeptides?
What sets us apart from other suppliers
Frequently Asked Questions
Common questions answered